Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Evaluating the Impact of GP and Practice Nurse Training in Self Regulations Skills on Patient Outcomes

The recruitment status of this study is unknown because the information has not been verified recently.
Verified June 2008 by University of Aberdeen.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
University of Aberdeen
ClinicalTrials.gov Identifier:
NCT00493090
First received: June 26, 2007
Last updated: June 3, 2008
Last verified: June 2008
  Purpose

This study will address the key question of developing shared understanding and negotiating mutually acceptable outcomes between people with asthma and healthcare professionals by applying theoretical knowledge of self regulation and communication skills learning and practice to asthma consultations. This study will facilitate integration of best practice into normal care using the BTS/SIGN asthma guidelines as the basis for structured care. This intervention has been show to be effective in the US. We aim to show that it can be effective in the UK setting in a cluster randomised control trial. We aim to modify and evaluate the intervention in such a way that it can be easily offered across UK primary care settings, with the possibility of significant benefits for patients. The intervention is based on the principle of empowering patients to manage their condition themselves, is consistent with the aims of Asthma UK, and, for this reason, we believe that Asthma UK may wish to be associated with this project.


Condition Intervention
Asthma
Behavioral: modification of an interactive seminar

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Health Services Research
Official Title: Effects of Patient-Centred Asthma Education for GPs and Practice Nurses:Evaluating the Impact of Training in Self Regulation Skills on Patient Outcomes:a Randomised Controlled Trial

Further study details as provided by University of Aberdeen:

Primary Outcome Measures:
  • The Juniper Mini Asthma Quality of Life Questionnaire (Mini AQLQ) (2) and the Medical Interview Satisfaction Scale (MISS-21). [ Time Frame: 1 year ]

Secondary Outcome Measures:
  • The Patients' Perception of their Involvement Questionnaire (PPIQ) (4) and the Asthma Control Questionnaire (ACQ) (5). [ Time Frame: 1 year ]

Estimated Enrollment: 360
Study Start Date: October 2005
Estimated Study Completion Date: July 2008
  Show Detailed Description

  Eligibility

Ages Eligible for Study:   18 Years to 55 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

Practice:

  • Registered with SPPIRe
  • List size > 5000
  • An asthma register
  • Electronic records
  • At least 1 GP and 1 Practice nurse commit to training
  • Commitment to ensuring questionnaire data is collected from 40 patients with poorly controlled asthma seen by either the GP or nurse

Patients:

  • Must be registered with recruited practices
  • Asthma diagnosis in excess of 12 months receiving regular preventative asthma therapy
  • Using in excess of twelve beta2 agonists during a twelve month period and/or experiencing an acute exacerbation of asthma requiring oral steroids in the last 12 months

Exclusion Criteria:

Practices:

  • Not registered with SPIRRe
  • Not reaching the inclusion criteria
  • Not wishing to take part.

Patients:

  • If they have well controlled asthma and do not experience any poor control.
  • Patients with physician-diagnosed predominantly irreversible airways disease.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00493090

Contacts
Contact: Jennifer Cleland 01224 553969 jen.cleland@abdn.ac.uk

Locations
United Kingdom
University of Aberdeen Recruiting
Aberdeen, United Kingdom, AB25 2AY
Contact: Mandy Moffat    01224 552485    m.moffat@abdn.ac.uk   
Principal Investigator: Jennifer Cleland         
Sponsors and Collaborators
University of Aberdeen
Investigators
Principal Investigator: Jennifer Cleland University of Aberdeen
  More Information

No publications provided

Responsible Party: Jennifer Cleland, University of Aberdeen
ClinicalTrials.gov Identifier: NCT00493090     History of Changes
Other Study ID Numbers: 05/015
Study First Received: June 26, 2007
Last Updated: June 3, 2008
Health Authority: United Kingdom: Research Ethics Committee

Keywords provided by University of Aberdeen:
Professional
patient partnership
patient satisfaction
professional training

Additional relevant MeSH terms:
Asthma
Bronchial Diseases
Hypersensitivity
Hypersensitivity, Immediate
Immune System Diseases
Lung Diseases
Lung Diseases, Obstructive
Respiratory Hypersensitivity
Respiratory Tract Diseases

ClinicalTrials.gov processed this record on November 25, 2014